PharVision Advisers’s Agree Realty ADC Stock Holding History

PharVision Advisers’s Portfolio ADC Stock Details ADC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,654	Closed	-$413K	–	655
2025 Q2	$413K	Buy	+5,654	New	+$425K	0.59%	21
2025 Q1	–	Sell	-3,120	Closed	-$220K	–	267
2024 Q4	$220K	Buy	+3,120	New	+$232K	0.19%	263

Other funds holding ADC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PharVision Advisers's ADC Position: Q3 2025 in Review

PharVision Advisers sold out of Agree Realty (ADC) in Q3 2025, closing a stake of 5,654 shares — an estimated $413K sold.

PharVision Advisers first reported a position in ADC in Q4 2024 and held it in 2 quarters. The position peaked at $413K in Q2 2025. 479 funds tracked by Wall St. Rank hold ADC as of Q3 2025.

PharVision Advisers reported no remaining Agree Realty position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 5,654 Agree Realty shares in Q3 2025, an estimated $413K.
PharVision Advisers first reported a position in Agree Realty in Q4 2024 and held it in 2 quarters.
PharVision Advisers's Agree Realty position peaked at $413K in Q2 2025.
479 funds tracked by Wall St. Rank held Agree Realty as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.